Lindbrook Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Lindbrook Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-240	Closed	-$2.96K	–	2965
2024 Q4	$2.96K	Hold	240	–	–	﹤0.01%	2185
2024 Q3	$2.73K	Sell	240 -63	-21%	-$632	﹤0.01%	2250
2024 Q2	$2.16K	Buy	303 +63	+26%	+$482	﹤0.01%	2323
2024 Q1	$1.61K	Hold	240	–	–	﹤0.01%	2311
2023 Q4	$1.56K	Buy	+240	New	+$1.55K	﹤0.01%	2347
2023 Q3	–	Sell	-25	Closed	-$301	–	2846
2023 Q2	$349	Buy	+25	New	+$426	﹤0.01%	2581
2022 Q4	–	Sell	-25	Closed	–	–	3041
2022 Q3	$0	Buy	+25	New	+$455	﹤0.01%	2960

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lindbrook Capital's CDMO Position: Q1 2025 in Review

Lindbrook Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 240 shares — an estimated $2.96K sold.

Lindbrook Capital first reported a position in CDMO in Q3 2022 and held it in 7 quarters. The position peaked at $2.96K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

Lindbrook Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Lindbrook Capital sold 240 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.96K.
Lindbrook Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Lindbrook Capital's Avid Bioservices, Inc. Common Stock position peaked at $2.96K in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.